Metropolis Healthcare Limited (BOM:542650)
India · Delayed Price · Currency is INR 556.65
+16.00 (2.96%)
At close: Aug 21, 2026
Metropolis Healthcare Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 17,100 | 16,458 | 13,312 | 12,077 | 11,482 | 12,283 |
Revenue Growth | 21.80% | 23.64% | 10.22% | 5.18% | -6.52% | 23.08% |
Gross Profit Gross Profit Growth | 13,293 | 12,732 | 10,282 | 9,378 | 8,742 | 9,307 |
Operating Income Operating Income Growth | 2,877 | 2,678 | 1,943 | 1,951 | 2,037 | 2,817 |
Net Income Net Income Growth | 2,016 | 1,900 | 1,450 | 1,278 | 1,429 | 2,142 |
Earnings Per Share EPS Growth | 10.10 | 9.19 | 7.00 | 6.22 | 6.95 | 10.41 |
EPS Growth | 37.11% | 31.29% | 12.58% | -10.57% | -33.25% | 16.40% |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 14,999 | 12,218 | 11,055 | 10,921 | 11,807 |
outside India outside India Growth | 1,459 | 1,094 | 1,022 | 561.05 | 476.31 |
Total Total Growth | 16,458 | 13,312 | 12,077 | 11,482 | 12,283 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,030 | 2,030 | 1,183 | 1,243 | 823.7 | 1,806 |
Total Debt Total Debt Growth | 2,319 | 2,319 | 2,041 | 1,971 | 2,664 | 3,786 |
Net Cash (Debt) Net Cash Growth | -289.47 | -289.47 | -858.68 | -727.74 | -1,840 | -1,980 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.45 | -1.40 | -4.15 | -3.54 | -8.96 | -9.63 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 3,507 | 2,627 | 2,641 | 2,471 | 2,533 |
Capital Expenditures CapEx Growth | - | -434.89 | -434.1 | -637.61 | -526.34 | -306.63 |
Free Cash Flow Free Cash Flow Growth | - | 3,072 | 2,193 | 2,003 | 1,945 | 2,226 |
Free Cash Flow Growth | - | 40.06% | 9.50% | 3.01% | -12.65% | 0.84% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 77.74% | 77.36% | 77.24% | 77.65% | 76.13% | 75.77% |
Operating Margin | 16.82% | 16.27% | 14.60% | 16.16% | 17.74% | 22.93% |
Pretax Margin | 16.12% | 15.75% | 14.34% | 14.46% | 16.33% | 23.88% |
Profit Margin | 11.79% | 11.54% | 10.89% | 10.58% | 12.44% | 17.44% |
FCF Margin | - | 18.67% | 16.48% | 16.59% | 16.94% | 18.12% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 2.000 | 2.000 | - | 1.000 | 2.000 | 2.000 |
Dividend Per Share Growth | 0% | - | - | -50.00% | 0% | 0% |
Dividend Yield | 0.36% | 0.46% | - | 0.23% | 0.65% | 0.40% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 57.27 | 47.35 | 55.33 | 69.08 | 44.74 | 48.64 |
P/FCF Ratio | 37.59 | 29.29 | 36.57 | 44.08 | 32.87 | 46.80 |
PS Ratio | 6.75 | 5.47 | 6.03 | 7.31 | 5.57 | 8.48 |